Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WARNER CHILCOTT COMPANY, LLC v. MYLAN, INC. et al
Case Number:
3:11-cv-03262
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 05, 2013
Warner Chilcott, Mylan Deal OK'd In Birth Control IP Row
A New Jersey federal judge Monday greenlighted a settlement agreement between pharmaceutical giant Warner Chilcott Co. LLC and generics maker Mylan Inc. in Warner Chilcott's suit over Mylan's plans for a generic version of its birth control drug Loestrin.
-
June 09, 2011
Warner Chilcott Sues Mylan Over Loestrin ANDA
Warner Chilcott Co. LLC filed a patent infringement suit in New Jersey on Thursday seeking to stop Mylan Inc. from releasing a generic form of birth control pill Loestrin.